Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03205787 · ClinicalTrials.gov registry record · NA
Red Clover Botanical Dietary Supplements - Metabolism and Safety in Women
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03205787 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 20 participants.
The verdict
NCT03205787, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Human safety studies were carried out to test whether red clover botanical dietary supplements used by peri- and post-menopausal women are safe to use with Food and Drug Administration (FDA)-approved drugs. To test this, a red clover dietary supplement (previously tested in women at the University of Illinois at Chicago without any harmful effects) was given with four selected FDA-approved drugs to determine if the red clover supplement can increase or decrease how these medications are absorbed, metabolized and excreted by the human body. Preclinical studies predicted that the red clover supplement might affect the metabolism or break down of these probe drugs.
Interventions
- DIETARY_SUPPLEMENT Trifolium pratense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2020-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03205787
The ClinicalTrials.gov registry entry for NCT03205787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trifolium pratense is the first listed.
NCT03205787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03205787 about?
NCT03205787 is a clinical study titled "Red Clover Botanical Dietary Supplements - Metabolism and Safety in Women". Human safety studies were carried out to test whether red clover botanical dietary supplements used by peri- and post-menopausal women are safe to use with Food and Drug Administration (FDA)-approved drugs. To test this, a red clover dietary supplement (previously tested in women at the University o...
What is the current status of trial NCT03205787?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-09-21. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03205787?
The interventions under investigation include: Trifolium pratense (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03205787?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.